The Clorox Company $CLX Stake Cut by Los Angeles Capital Management LLC

Los Angeles Capital Management LLC lessened its holdings in shares of The Clorox Company (NYSE:CLXFree Report) by 61.9% during the 2nd quarter, HoldingsChannel reports. The fund owned 83,114 shares of the company’s stock after selling 134,907 shares during the period. Los Angeles Capital Management LLC’s holdings in Clorox were worth $9,979,000 as of its most recent SEC filing.

Other hedge funds have also made changes to their positions in the company. American National Bank & Trust grew its position in Clorox by 69.5% during the second quarter. American National Bank & Trust now owns 217 shares of the company’s stock valued at $26,000 after purchasing an additional 89 shares in the last quarter. NewSquare Capital LLC boosted its stake in shares of Clorox by 567.6% during the 2nd quarter. NewSquare Capital LLC now owns 227 shares of the company’s stock valued at $27,000 after buying an additional 193 shares during the period. Hantz Financial Services Inc. purchased a new position in shares of Clorox during the 2nd quarter valued at $31,000. Ransom Advisory Ltd purchased a new position in shares of Clorox during the 1st quarter valued at $35,000. Finally, GW&K Investment Management LLC increased its stake in shares of Clorox by 239.1% in the first quarter. GW&K Investment Management LLC now owns 295 shares of the company’s stock worth $43,000 after acquiring an additional 208 shares during the last quarter. 78.53% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

CLX has been the topic of a number of recent research reports. Deutsche Bank Aktiengesellschaft lowered their target price on Clorox from $128.00 to $121.00 and set a “hold” rating on the stock in a research note on Tuesday, November 4th. Morgan Stanley lowered their price target on Clorox from $137.00 to $125.00 and set an “equal weight” rating for the company in a research note on Tuesday, November 4th. Barclays dropped their price objective on Clorox from $112.00 to $108.00 and set an “underweight” rating on the stock in a report on Tuesday, November 4th. Rothschild & Co Redburn reduced their target price on shares of Clorox from $120.00 to $115.00 and set a “neutral” rating for the company in a research note on Wednesday, November 5th. Finally, Citigroup decreased their target price on shares of Clorox from $130.00 to $120.00 and set a “neutral” rating for the company in a research report on Tuesday, November 4th. One investment analyst has rated the stock with a Buy rating, twelve have given a Hold rating and five have issued a Sell rating to the company’s stock. According to MarketBeat, the company has an average rating of “Reduce” and a consensus price target of $125.69.

Check Out Our Latest Research Report on Clorox

Clorox Trading Up 1.0%

Shares of CLX stock opened at $107.37 on Monday. The Clorox Company has a 12 month low of $106.14 and a 12 month high of $171.37. The company has a market cap of $13.10 billion, a PE ratio of 16.47, a price-to-earnings-growth ratio of 0.92 and a beta of 0.52. The company has a quick ratio of 0.57, a current ratio of 0.84 and a debt-to-equity ratio of 5.15. The business’s 50 day moving average is $119.49 and its two-hundred day moving average is $124.72.

Clorox (NYSE:CLXGet Free Report) last posted its quarterly earnings data on Monday, November 3rd. The company reported $0.85 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.78 by $0.07. Clorox had a net margin of 11.40% and a return on equity of 377.86%. The business had revenue of $1.43 billion during the quarter, compared to the consensus estimate of $1.41 billion. During the same period in the prior year, the firm earned $1.86 EPS. Clorox’s quarterly revenue was down 18.9% compared to the same quarter last year. Clorox has set its FY 2026 guidance at 5.950-6.300 EPS. Equities analysts predict that The Clorox Company will post 7.15 EPS for the current year.

Clorox Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Thursday, November 6th. Stockholders of record on Wednesday, October 22nd were given a $1.24 dividend. This represents a $4.96 annualized dividend and a dividend yield of 4.6%. The ex-dividend date of this dividend was Wednesday, October 22nd. Clorox’s dividend payout ratio (DPR) is currently 77.86%.

Insider Activity at Clorox

In other news, COO Eric H. Reynolds sold 15,041 shares of Clorox stock in a transaction dated Thursday, September 4th. The stock was sold at an average price of $123.78, for a total value of $1,861,774.98. Following the transaction, the chief operating officer directly owned 54,221 shares in the company, valued at approximately $6,711,475.38. The trade was a 21.72% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Insiders own 0.63% of the company’s stock.

Clorox Company Profile

(Free Report)

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.

Further Reading

Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLXFree Report).

Institutional Ownership by Quarter for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.